AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Jul 14, 2016

30071_dirs_2016-07-14_2f5e3e96-ad9b-4b54-9492-dfc486ca4ed2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-07-14

Reporting Person: Hollingshead James (President, Americas)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-14	ResMed Common Stock	S	2753	$65.0177	Disposed	40669	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $65.00 to $65.10. The price reported above reflects the weighted average sale price.